Your browser doesn't support javascript.
loading
Discovery and functional interrogation of SARS-CoV-2 protein-RNA interactions.
Xiang, Joy S; Mueller, Jasmine R; Luo, En-Ching; Yee, Brian A; Schafer, Danielle; Schmok, Jonathan C; Tan, Frederick E; Rothamel, Katherine; McVicar, Rachael N; Kwong, Elizabeth M; Jones, Krysten L; Her, Hsuan-Lin; Chen, Chun-Yuan; Vu, Anthony Q; Jin, Wenhao; Park, Samuel S; Le, Phuong; Brannan, Kristopher W; Kofman, Eric R; Li, Yanhua; Tankka, Alexandra T; Dong, Kevin D; Song, Yan; Carlin, Aaron F; Van Nostrand, Eric L; Leibel, Sandra L; Yeo, Gene W.
Affiliation
  • Xiang JS; Institute of Molecular and Cellular Biology, A*STAR, Singapore.
  • Mueller JR; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Luo EC; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Yee BA; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Schafer D; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Schmok JC; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Tan FE; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Rothamel K; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • McVicar RN; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Kwong EM; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
  • Jones KL; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
  • Her HL; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Chen CY; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Vu AQ; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Jin W; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Park SS; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Le P; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Brannan KW; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Kofman ER; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Li Y; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Tankka AT; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Dong KD; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Song Y; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Carlin AF; Department of Cellular and Molecular Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA.
  • Van Nostrand EL; Department of Medicine, University of California, San Diego, La Jolla, CA 92037, USA.
  • Leibel SL; Verna & Marrs McLean Department of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Yeo GW; Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, CA 92037, USA.
bioRxiv ; 2022 Feb 23.
Article de En | MEDLINE | ID: mdl-35233578
ABSTRACT
The COVID-19 pandemic is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). The betacoronvirus has a positive sense RNA genome which encodes for several RNA binding proteins. Here, we use enhanced crosslinking and immunoprecipitation to investigate SARS-CoV-2 protein interactions with viral and host RNAs in authentic virus-infected cells. SARS-CoV-2 proteins, NSP8, NSP12, and nucleocapsid display distinct preferences to specific regions in the RNA viral genome, providing evidence for their shared and separate roles in replication, transcription, and viral packaging. SARS-CoV-2 proteins expressed in human lung epithelial cells bind to 4773 unique host coding RNAs. Nine SARS-CoV-2 proteins upregulate target gene expression, including NSP12 and ORF9c, whose RNA substrates are associated with pathways in protein N-linked glycosylation ER processing and mitochondrial processes. Furthermore, siRNA knockdown of host genes targeted by viral proteins in human lung organoid cells identify potential antiviral host targets across different SARS-CoV-2 variants. Conversely, NSP9 inhibits host gene expression by blocking mRNA export and dampens cytokine productions, including interleukin-1α/ß. Our viral protein-RNA interactome provides a catalog of potential therapeutic targets and offers insight into the etiology of COVID-19 as a safeguard against future pandemics.

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: BioRxiv Année: 2022 Type de document: Article Pays d'affiliation: Singapour

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: BioRxiv Année: 2022 Type de document: Article Pays d'affiliation: Singapour
...